The flu strain, known as “G4 EA H1N1,” has characteristics similar to the strains responsible for the 2009 H1N1 pandemic and 1918 Spanish flu pandemic.
Dr. Fauci, director of the National Institute of Allergy and Infectious Diseases, said there is no evidence to prove that the new flu strain can infect humans, but he noted the virus is exhibiting “reassortment capabilities,” according to CNBC.
“In other words, when you get a brand new virus that turns out to be a pandemic virus it’s either due to mutations and/or the reassortment or exchanges of genes,” Dr. Fauci said.
The new virus is not “an immediate threat where you’re seeing infections, but it’s something we need to keep our eye on, just the way we did in 2009 with the emergence of the swine flu,” he said.
More articles on public health:
How COVID-19 affects the brain: 4 things to know
Where new COVID-19 cases are rising, falling and staying the same — June 29
‘Worst is yet to come,’ WHO chief says; Hospitalizations up in 7 states — 6 COVID-19 updates
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
